Form 8-K - Current report:
SEC Accession No. 0001193125-24-262560
Filing Date
2024-11-20
Accepted
2024-11-20 16:33:55
Documents
13
Period of Report
2024-11-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d856064d8k.htm   iXBRL 8-K 24377
  Complete submission text file 0001193125-24-262560.txt   145893

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dawn-20241120.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20241120_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20241120_pre.xml EX-101.PRE 11266
15 EXTRACTED XBRL INSTANCE DOCUMENT d856064d8k_htm.xml XML 3654
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 241480863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)